Hongyuan Zhang1,2, Benjamin A Alman3,4. 1. Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA. 2. Department of Cell Biology, Duke University School of Medicine, Durham, NC, 27710, USA. 3. Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC, 27710, USA. ben.alman@duke.edu. 4. Department of Cell Biology, Duke University School of Medicine, Durham, NC, 27710, USA. ben.alman@duke.edu.
Abstract
PURPOSE OF REVIEW: Enchondroma is a common cartilage benign tumor that develops from dysregulation of chondrocyte terminal differentiation during growth plate development. Here we provide an overview of recent progress in understanding causative mutations for enchondroma, dysregulated signaling and metabolic pathways in enchondroma, and the progression from enchondroma to malignant chondrosarcoma. RECENT FINDINGS: Several signaling pathways that regulate chondrocyte differentiation are dysregulated in enchondromas. Somatic mutations in the metabolic enzymes isocitrate dehydrogenase 1 and 2 (IDH1/2) are the most common findings in enchondromas. Mechanisms including metabolic regulation, epigenetic regulation, and altered signaling pathways play a role in enchondroma formation and progression. Multiple pathways regulate growth plate development in a coordinated manner. Deregulation of the process can result in chondrocytes failing to undergo differentiation and the development of enchondroma.
PURPOSE OF REVIEW: Enchondroma is a common cartilage benign tumor that develops from dysregulation of chondrocyte terminal differentiation during growth plate development. Here we provide an overview of recent progress in understanding causative mutations for enchondroma, dysregulated signaling and metabolic pathways in enchondroma, and the progression from enchondroma to malignant chondrosarcoma. RECENT FINDINGS: Several signaling pathways that regulate chondrocyte differentiation are dysregulated in enchondromas. Somatic mutations in the metabolic enzymes isocitrate dehydrogenase 1 and 2 (IDH1/2) are the most common findings in enchondromas. Mechanisms including metabolic regulation, epigenetic regulation, and altered signaling pathways play a role in enchondroma formation and progression. Multiple pathways regulate growth plate development in a coordinated manner. Deregulation of the process can result in chondrocytes failing to undergo differentiation and the development of enchondroma.
Authors: Charles K F Chan; Eun Young Seo; James Y Chen; David Lo; Adrian McArdle; Rahul Sinha; Ruth Tevlin; Jun Seita; Justin Vincent-Tompkins; Taylor Wearda; Wan-Jin Lu; Kshemendra Senarath-Yapa; Michael T Chung; Owen Marecic; Misha Tran; Kelley S Yan; Rosalynd Upton; Graham G Walmsley; Andrew S Lee; Debashis Sahoo; Calvin J Kuo; Irving L Weissman; Michael T Longaker Journal: Cell Date: 2015-01-15 Impact factor: 66.850
Authors: Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner Journal: N Engl J Med Date: 2009-02-19 Impact factor: 176.079
Authors: Lucia Salamanca-Cardona; Hardik Shah; Alex J Poot; Fabian M Correa; Valentina Di Gialleonardo; Hui Lui; Vesselin Z Miloushev; Kristin L Granlund; Sui S Tee; Justin R Cross; Craig B Thompson; Kayvan R Keshari Journal: Cell Metab Date: 2017-10-19 Impact factor: 31.373
Authors: Hongyuan Zhang; Vijitha Puviindran; Puviindran Nadesan; Xiruo Ding; Leyao Shen; Yuning J Tang; Hidetoshi Tsushima; Yasuhito Yahara; Ga I Ban; Guo-Fang Zhang; Courtney M Karner; Benjamin A Alman Journal: J Bone Miner Res Date: 2022-03-22 Impact factor: 6.390